Question 1

Does HighTower Advisors own CYTK stock?

Accepted Answer

Yes. As of its Q2 2026 13F, HighTower Advisors holds 13,409 shares of CYTK (Cytokinetics), worth $1.1M.

Question 2

How many shares of CYTK does HighTower Advisors own?

Accepted Answer

As of its Q2 2026 13F, HighTower Advisors holds 13,409 shares of CYTK (Cytokinetics).

Question 3

What is HighTower Advisors' CYTK position worth?

Accepted Answer

As of its Q2 2026 13F, HighTower Advisors' CYTK position is worth $1.1M.

Question 4

Is HighTower Advisors buying or selling CYTK?

Accepted Answer

In Q2 2026, HighTower Advisors reduced its CYTK position by 3,222 shares (-19.4%).

Question 5

When did HighTower Advisors first buy CYTK?

Accepted Answer

HighTower Advisors already held CYTK in its Q4 2018 13F, the earliest on record, and has listed it in 31 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	13,409	-19.4%	$1.1M	0.0%	$85.19	0
2026-Q1	Increased	16,631	+19.5%	$1.1M	0.0%	$65.91	30
2025-Q4	Increased	13,913	+8.7%	$884,032	0.0%	$63.54	27
2025-Q3	Increased	12,800	+22.8%	$703,488	0.0%	$54.96	30
2025-Q2	Decreased	10,423	-8.2%	$344,376	0.0%	$33.04	0
2025-Q1	Increased	11,352	+21.8%	$456,237	0.0%	$40.19	29
2024-Q4	Decreased	9,323	-13.7%	$438,554	0.0%	$47.04	0
2024-Q3	Decreased	10,804	-0.4%	$568,000	0.0%	$52.80	0